IntraCrop Limited – Trademark Portfolio

Entity Type: 99

IntraCrop Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MTU and INTRACROP.

Weston Centre,

10 Grosvenor Street London W1K 4QY

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

INTRACROP
INTRACROP
Registered 2025
STATUS
STATUS
Cancelled 2023
MTU
MTU
Registered 2022

Trademark Classifications

IntraCrop Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does IntraCrop Limited have?

IntraCrop Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does IntraCrop Limited file in?

IntraCrop Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are IntraCrop Limited's most well-known trademarks?

IntraCrop Limited's registered trademark portfolio includes well-known marks such as MTU and INTRACROP. These are among 2 currently registered trademarks in the portfolio.

What is IntraCrop Limited's trademark registration success rate?

IntraCrop Limited has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.